全球持续气道正压通气 (CPAP) 市场 – 行业趋势和 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球持续气道正压通气 (CPAP) 市场 – 行业趋势和 2031 年预测

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Cpap Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 512.00 Million
Diagram Market Size (Forecast Year)
USD 847.36 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球持续气道正压通气 (CPAP) 市场,按产品类型(固定压力 CPAP 设备、自动调节 CPAP 设备、CPAP 电机、CPAP 软管、CPAP 面罩、其他)、应用(住宅、医院、其他)、功能(加湿器、便携性、加热管)、自动化(手动、自动)– 行业趋势和预测到 2031 年。

持续气道正压通气 (CPAP) 市场

 

持续气道正压通气 (CPAP) 市场分析和规模

预计在预测期内推动持续气道正压通气 (CPAP) 市场增长的主要因素是推动创新的初创企业数量的增加。此外,阻塞性睡眠呼吸暂停发病率的增加预计将进一步推动市场的增长。此外,老年人口中呼吸系统疾病发病率的上升预计将进一步减缓市场的增长。

Data Bridge Market Research 分析,持续气道正压通气 (CPAP) 市场规模在 2023 年为 5.12 亿美元,到 2031 年可能达到 8.4736 亿美元,预计在预测期内的复合年增长率为 6.5%。由于对更好的患者治疗方法的需求不断增长,“固定压力 CPAP 设备”在市场产品类型细分中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

报告范围和市场细分

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(百万美元)、销量(单位)和定价(美元)

涵盖的领域

按产品类型(固定压力 CPAP 设备、自动调节 CPAP 设备、CPAP 电机、CPAP 软管、CPAP 面罩、其他)、应用(住宅、医院、其他)、功能(加湿器、便携性、加热管)、自动化(手动、自动)

覆盖国家

美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区

涵盖的市场参与者

Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), 3B Medical, Inc. (U.S.), ARMSTRONG MEDICAL (Ireland), ResMed (U.S.), Smiths Medical (U.S.), APEX MEDICAL CORP. (Taiwan), Fisher & Paykel Healthcare Limited. (New Zealand), Cardinal Health. (U.S.), DeVilbiss Healthcare LLC (U.S.), Invacare Corporation (U.S.), Shanghai Fosun Pharmaceutical (Group)Co., Ltd. (China), KOIKE MEDICAL CO., LTD. (Japan), TEIJIN LIMITED. (Japan), Curative Medical. (U.S.), NIDEK CO., LTD. (Japan), Breas Medical AB (Sweden), WEINMANN Emergency Medical Technology GmbH+ Co. KG (Germany)

Market Opportunities

  • Growing awareness and diagnosis of sleep apnea
  • Expansion in emerging markets

Market Definition

Continuous positive airway pressure (CPAP) is known to be a treatment which is utilized to moderate the severe obstructive sleep apnea. Generally, people with obstructive sleep apnea have to wear a face mask that is attached to a pump which pushes air into the nasal passages at high enough pressure to release the airway obstructions and enable normal breathing while sleeping.

Global  Continuous Positive Airway Pressure (CPAP) Market Dynamics

Drivers

  • Increasing prevalence of sleep apnea

Sleep apnea is a common sleep disorder characterized by pauses in breathing or shallow breaths during sleep. The prevalence of sleep apnea is increasing globally due to factors such as obesity, sedentary lifestyles, and aging populations. CPAP therapy is considered the gold standard treatment for sleep apnea, providing a continuous flow of pressurized air to keep the airway open. The growing prevalence of sleep apnea drives the demand for CPAP devices and contributes to the growth of the CPAP market.

  • Technological advancements in CPAP devices

Continuous advancements in CPAP device technology have led to the development of more comfortable, user-friendly, and efficient devices. New features such as automatic pressure adjustment, integrated humidifiers, smaller and quieter devices, and wireless connectivity have improved patient compliance and comfort. These technological advancements have made CPAP therapy more accessible and appealing to patients, driving the demand for CPAP devices and expanding the CPAP market.

Opportunities

  • Growing awareness and diagnosis of sleep apnea

Despite the increasing prevalence of sleep apnea, a significant portion of cases remain undiagnosed. As awareness about the health risks associated with untreated sleep apnea grows, more individuals are seeking diagnosis and treatment. This presents an opportunity for the CPAP market to expand as more patients are identified and prescribed CPAP therapy. Increased awareness campaigns, educational initiatives, and screening programs can further drive the demand for CPAP devices.

  • Expansion in emerging markets

The CPAP market has significant growth potential in emerging markets due to factors such as increasing healthcare expenditure, rising awareness about sleep disorders, and improving access to healthcare services. As these markets continue to develop and invest in healthcare infrastructure, there is an opportunity for CPAP manufacturers to tap into these markets and provide affordable and accessible solutions for sleep apnea management. Adapting to the specific needs and preferences of these markets, such as offering cost-effective devices and local language support, can help companies capture a larger market share and drive growth in emerging markets.

Restraints/Challenges

  • Cost of CPAP devices and therapy

CPAP devices and related accessories can be expensive, making them less accessible to individuals with limited financial resources or inadequate insurance coverage. The high cost of CPAP devices and ongoing maintenance can act as a restraint for some patients, preventing them from pursuing or continuing CPAP therapy. The affordability and accessibility of CPAP devices and therapy remain a challenge for the market.

  • Patient compliance and adherence

CPAP therapy requires consistent and long-term use for optimal effectiveness. However, achieving and maintaining high levels of patient compliance and adherence can be challenging. Some patients may struggle to adjust to wearing the mask, experience discomfort, or find it difficult to use the device consistently throughout the night. Lack of compliance and adherence can lead to suboptimal treatment outcomes and reduced efficacy of CPAP therapy. Educating patients about the importance of adherence, providing ongoing support, and addressing barriers to compliance are essential challenges for the CPAP market to ensure successful long-term treatment outcomes.

This continuous positive airway pressure (CPAP) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the continuous positive airway pressure (CPAP) market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • On March 4, 2021, ResMed, a leading manufacturer of CPAP devices, announced the launch of its AirSense 11 CPAP device. The AirSense 11 features advanced technology, including improved humidification, quieter operation, and enhanced connectivity for remote monitoring and therapy management
  • 2020 年 10 月,飞利浦推出了 DreamStation 2 CPAP 设备。DreamStation 2 是一款小巧且用户友好的设备,提供自动压力调节、集成加湿和无线连接等高级功能,用于数据跟踪和远程监控

全球持续气道正压通气 (CPAP) 市场范围

持续气道正压通气 (CPAP) 市场根据产品类型、应用、功能和自动化进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

类型

  • 固定压力 CPAP 装置
  • 自动调节 CPAP 装置
  • CPAP 电机
  • CPAP 软管
  • CPAP 面罩
  • 其他的

应用

  • 住宅
  • 医院
  • 其他的

特征

  • 加湿器
  • 可移植性
  • 加热管

自动化

  • 手动的
  • 自动的

全球持续气道正压通气 (CPAP) 市场区域分析/见解

对持续气道正压通气 (CPAP) 市场进行了分析,并按国家、产品类型、应用、功能和自动化提供了市场规模洞察和趋势(如上所述)。

市场报告涉及的国家包括美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区。

由于对持续气道正压通气机的需求不断增长,北美预计将占据市场主导地位。此外,预测期内睡眠障碍发病率的上升将进一步促进该地区市场的增长。  

由于慢性睡眠障碍发病率上升,预计亚太地区在 2024 年至 2031 年的预测期内将出现显著增长。此外,患者警觉性不断提高预计将在未来几年进一步推动该地区市场的增长。

报告的国家部分还提供了影响单个市场影响因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。   

医疗保健基础设施增长安装基础和新技术渗透

持续气道正压通气(CPAP)市场还为您提供了详细的市场分析,包括每个国家在资本设备医疗保健支出的增长情况、持续气道正压通气(CPAP)市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管场景的变化及其对持续气道正压通气(CPAP)市场的影响。

竞争格局和持续气道正压通气 (CPAP) 市场份额分析

持续气道正压通气 (CPAP) 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对持续气道正压通气 (CPAP) 市场的关注有关。

持续气道正压通气 (CPAP) 市场的一些主要参与者包括:

  •  美敦力(爱尔兰)
  • Koninklijke Philips NV(荷兰)
  • 3B Medical, Inc.(美国)
  • 阿姆斯特朗医疗公司(爱尔兰)
  • ResMed(美国)
  • Smiths Medical(美国)
  • 鼎泰醫療股份有限公司 (台灣)
  • Fisher & Paykel Healthcare Limited.(新西兰)
  • 卡地纳健康公司(Cardinal Health)。(美国)
  • DeVilbiss Healthcare LLC(美国)
  • Invacare 公司 (美国)
  • 上海复星医药(集团)股份有限公司 (中国)
  • 小池医疗株式会社(日本)
  • 帝人株式会社(日本)
  • 治疗医学。(美国)
  • 尼德克株式会社(日本)
  • Breas Medical AB(瑞典)
  • WEINMANN 急救医疗技术有限公司 (德国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Continuous Positive Airway Pressure (CPAP) Market size will be worth USD 847.36 million by 2030.
The Continuous Positive Airway Pressure (CPAP) Market growth rate is 6.5% during the forecast period.
The Increasing prevalence of sleep apnea and Technological advancements in CPAP devices are the growth drivers of the Continuous Positive Airway Pressure (CPAP) Market.
The product type, application, features, and automation are the factors on which the Continuous Positive Airway Pressure (CPAP) Market research is based.
The major companies in the Continuous Positive Airway Pressure (CPAP) Market are Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), 3B Medical, Inc. (U.S.), ARMSTRONG MEDICAL (Ireland), ResMed (U.S.), Smiths Medical (U.S.), APEX MEDICAL CORP. (Taiwan), Fisher & Paykel Healthcare Limited. (New Zealand), Cardinal Health. (U.S.), DeVilbiss Healthcare LLC (U.S.), Invacare Corporation (U.S.), Shanghai Fosun Pharmaceutical (Group)Co., Ltd. (China), KOIKE MEDICAL CO., LTD. (Japan), TEIJIN LIMITED. (Japan), Curative Medical. (U.S.), NIDEK CO., LTD. (Japan), Breas Medical AB (Sweden), WEINMANN Emergency Medical Technology GmbH+ Co. KG (Germany).